Women's perceptions and experience of adjuvant tamoxifen therapy account for their adherence: breast cancer patients' point of view

被引:70
作者
Pellegrini, Isabelle [1 ]
Sarradon-Eck, Aline [2 ]
Ben Soussan, Patrick [3 ]
Lacour, Anne-Claude [3 ]
Largillier, Remy [4 ]
Tallet, Agnes [3 ]
Tarpin, Carole [3 ]
Julian-Reynier, Claire [1 ]
机构
[1] INSERM, U912, SE4S, F-13273 Marseille 9, France
[2] Univ Paul Cezanne, CReCSS, Aix En Provence, France
[3] Inst Paoli Calmettes, Marseille, France
[4] Hop Antoine Lacassagne, Nice, France
关键词
breast cancer; oncology; tamoxifen; adherence; menopause; qualitative study; OLDER WOMEN; RANDOMIZED-TRIALS; INFORMATION NEEDS; DECISION-MAKING; YOUNGER WOMEN; MENOPAUSE; DISCONTINUATION; DIAGNOSIS; BELIEFS; NONCOMPLIANCE;
D O I
10.1002/pon.1593
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The aim of this study on primary breast cancer patients undergoing adjuvant tamoxifen treatment was to determine how their perceptions of the treatment and their experience of side-effects contributed to their adherence to the treatment. Methods: A consecutive series of primary breast cancer patients eligible for tamoxifen therapy were studied qualitatively by conducting semi-structured in-depth interviews at two French cancer centres. Results: The women aged 35-65 (N = 34) were struggling with several issues involving their understanding and experience of the treatment, which have not been documented so far. These issues included confusion about the 'hormonal' nature and activity of tamoxifen and the etiology of the changes in their menopausal status, as well as the symbolic associations formed by patients about the paradox of taking a treatment that has aging effects but saves lives. Conclusions: This study shows the great physical burden often associated with tamoxifen treatment and brings to light women's own complex representations of the treatment and their interpretation of the side-effects. Better communication between health-care providers and patients should ultimately help to prevent refusal or discontinuation of tamoxifen treatment. Copyright (C) 2009 John Wiley & Sons, Ltd.
引用
收藏
页码:472 / 479
页数:8
相关论文
共 38 条
  • [1] Intentional and non-intentional non-adherence to medication amongst breast cancer patients
    Atkins, Louise
    Fallowfield, Lesley
    [J]. EUROPEAN JOURNAL OF CANCER, 2006, 42 (14) : 2271 - 2276
  • [2] Early discontinuation of tamoxifen - A lesson for oncologists
    Barron, Thomas I.
    Connolly, Roisin M.
    Bennett, Kathleen
    Feely, John
    Kennedy, M. John
    [J]. CANCER, 2007, 109 (05) : 832 - 839
  • [3] THE EFFECTS OF PHYSICIAN COMMUNICATIONS SKILLS ON PATIENT SATISFACTION - RECALL, AND ADHERENCE
    BARTLETT, EE
    GRAYSON, M
    BARKER, R
    LEVINE, DM
    GOLDEN, A
    LIBBER, S
    [J]. JOURNAL OF CHRONIC DISEASES, 1984, 37 (9-10): : 755 - 764
  • [4] Baum M, 2003, Cancer, V98, P1802
  • [5] BRITTEN N, 1994, BRIT J GEN PRACT, V44, P465
  • [6] DISCOVERING CHRONIC ILLNESS - USING GROUNDED THEORY
    CHARMAZ, K
    [J]. SOCIAL SCIENCE & MEDICINE, 1990, 30 (11) : 1161 - 1172
  • [7] Clarke M, 1998, LANCET, V351, P1451
  • [8] Clarke R, 2001, PHARMACOL REV, V53, P25
  • [9] Health-related quality of life and tamoxifen in breast cancer prevention: A report from the National Surgical Adjuvant Breast and Bowel Project P-1 study
    Day, R
    Ganz, PA
    Costantino, JP
    Cronin, WM
    Wickerham, DL
    Fisher, B
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) : 2659 - 2669
  • [10] Adjuvant tamoxifen: Predictors of use, side effects, and discontinuation in older women
    Demissie, S
    Silliman, RA
    Lash, TL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (02) : 322 - 328